Shift4 Payments FOUR 深 沪
已收盘 10-17 16:00:00 美东时间
73.88
-0.200
-0.27%
华盛通- 最 高75.68
- 今 开73.79
- 成交量 149.24万股
- 最 低 73.69
- 昨 收 74.08
- 总市值 50.70亿
- 52周最高 127.50
- 市盈率 静 24.37
- 换手率 2.17%
- 52周最低 68.09
- 委 比 -47.06%
- 总股本 6863.01万
- 历史最高 127.50
- 量 比 0.75
- 振 幅 2.69%
- 历史最低 29.39
- 每 手 1
- 风险率 11.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ASHFORD TRUST DECLARES PREFERRED DIVIDENDS FOR THE FOURTH QUARTER OF 2025
DALLAS, Oct. 14, 2025 /PRNewswire/ -- Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") announced today that its Board of Directors (the "Board") declared a divi...
10-15 04:45
SmartPay Proposes Acquisition by Shift4 Payments
SmartPay Holdings Limited ( ($DE:KX2) ) has provided an announcement. SmartPay ...
10-14 06:57
Looking Into Shift4 Payments Inc's Recent Short Interest
Shift4 Payments Inc's (NYSE:FOUR) short interest as a percent of float has rise...
10-14 03:00
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
Raymond James Maintains Strong Buy on Shift4 Payments, Lowers Price Target to $120
Raymond James analyst John Davis maintains Shift4 Payments (NYSE:FOUR) with a Strong Buy and lowers the price target from $126 to $120.
10-11 02:06
'Billionaire Isaacman Met With Trump Over Top NASA Job' - Bloomberg News
https://www.bloomberg.com/news/articles/2025-10-09/billionaire-isaacman-said-to-talk-with-trump-over-top-nasa-job
10-10 01:10
美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
10-09 10:51
Shift4 Payments declares $1.50 dividend
Shift4 Payments (NYSE:FOUR) declares $1.50/share dividend. Payable Nov. 3; for shareholders of record Oct. 15; ex-div Oct. 15. See FOUR Dividend Scorecard, Yield Chart, & Dividend Growth. More on Shif...
10-06 20:13
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
